Litcius/Paper detail

Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma

Shuying Chen, Yinqi Mao, Wei Chen, Chenbin Liu, Han Wu, Jingjun Zhang, Shenghao Wang, Chengpan Wang, Yong Lin, Yuan Lv

2022Journal of Cancer41 citationsDOIOpen Access PDF

Abstract

Background: Circulating exosomal microRNAs (miRNAs) are considered as potentially non-invasive biomarkers for early detection and prognosis of cancers. Due to the lack of highly sensitive and specific molecular markers, a lot of patients with hepatocellular carcinoma are diagnosed in advanced stages. This study aims to explore the expression mode and clinical detection value of serum exosomal miR-34a in HCC, providing new potential targets and theoretical basis for the early diagnosis and prognosis monitoring of hepatocellular carcinoma. Methods: The expression of serum exosomal miR-34a in 60 HCC patients before and after operation and 60 healthy examiners was abstracted and detected by ultracentrifugation and real-time quantitative PCR. Using ROC analysis, Kaplan-Meier survival analysis and Cox regression analysis, the value of serum exosomal miR-34a on diagnosis and prognosis in HCC patients was assessed.

Topics & Concepts

MedicineHepatocellular carcinomaInternal medicineBiomarkerOncologyCirrhosismicroRNAProportional hazards modelStage (stratigraphy)GastroenterologyLymph node metastasisMetastasisCancerGeneChemistryBiochemistryBiologyPaleontologyExtracellular vesicles in diseaseMicroRNA in disease regulationCircular RNAs in diseases
Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma | Litcius